A Phase 1 Trial of Lapatinib in Combination With 1) Sirolimus or 2) Metformin in Advanced Cancer.

Trial Profile

A Phase 1 Trial of Lapatinib in Combination With 1) Sirolimus or 2) Metformin in Advanced Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2015

At a glance

  • Drugs Lapatinib (Primary) ; Metformin (Primary) ; Sirolimus (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 Apr 2013 Status changed from active, no longer recruiting to recruiting as reported by M.D. Anderson Cancer Center record.
    • 24 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top